Piet Wigerinck
Company: Fibrocor Therapeutics
Job title: Chief Scientific Advisor
Seminars:
Blocking the Matrix Stiffness Signal: From Patient to Clinical Candidate 2:00 pm
• Interrogation of progressive patients biopsies, a unique approach to fibrosis • Exploring the matrix stiffness and its untapped promise as an alternative approach in IPF • Leveraging tissue biomarkers to guide dose selection Read more
day: Day Two Track A PM